Neogen (NASDAQ:NEOG) Posts Earnings Results, Beats Expectations By $0.12 EPS

Neogen (NASDAQ:NEOG) posted its earnings results on Friday. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.12, Briefing.com reports. The company had revenue of $231.30 million for the quarter, compared to analyst estimates of $227.16 million. Neogen had a positive return on equity of 2.80% and a negative net margin of 2.58%. The firm’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.11 earnings per share. Neogen updated its FY 2025 guidance to EPS.

Neogen Stock Performance

Shares of Neogen stock opened at $12.36 on Friday. The company has a 50 day moving average price of $13.50 and a 200 day moving average price of $15.07. The firm has a market capitalization of $2.68 billion, a P/E ratio of -112.36 and a beta of 1.23. The company has a quick ratio of 2.79, a current ratio of 4.41 and a debt-to-equity ratio of 0.28. Neogen has a 52 week low of $11.46 and a 52 week high of $18.75.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. StockNews.com upgraded shares of Neogen to a “sell” rating in a research note on Monday, September 30th. Guggenheim assumed coverage on Neogen in a report on Thursday, December 19th. They set a “buy” rating and a $15.00 price objective for the company.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.